Related Experiment Video
Updated: Jun 26, 2025

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
Published on: June 26, 2020
Current perspectives of viral hepatitis
Daisuke Usuda1, Yuki Kaneoka2, Rikuo Ono2
1Department of Emergency and Critical Care Medicine, Juntendo University Nerima Hospital, Nerima 177-8521, Tokyo, Japan. d.usuda.qa@juntendo.ac.jp.
Viral hepatitis, a major global health threat, encompasses five distinct viruses (Hepatitis A-E). Current treatments can prevent advanced disease, but safer, shorter therapies are needed for eradication.
Area of Science:
- Hepatology
- Virology
- Public Health
Background:
- Viral hepatitis is a leading global cause of mortality and liver disease.
- Five distinct hepatitis viruses (A, B, C, D, E) present unique challenges.
- Despite available treatments, chronic viral hepatitis remains a significant public health concern.
Purpose of the Study:
- To review the current understanding of each viral hepatitis type.
- To highlight recent innovations in viral hepatitis management and treatment.
- To inform strategies for the global eradication of viral hepatitis by 2030.
Main Methods:
- Comprehensive literature review of viral hepatitis epidemiology, pathogenesis, and treatment.
- Analysis of current therapeutic options and their limitations.
- Examination of global health initiatives for viral hepatitis elimination.
Main Results:
- Each hepatitis virus (A-E) exhibits distinct characteristics in transmission, pathology, and treatment response.
- Existing therapies can halt disease progression, but challenges remain in achieving complete viral clearance and preventing long-term complications.
- The World Health Organization has outlined a plan for viral hepatitis elimination by 2030, emphasizing the need for improved diagnostics and therapeutics.
Conclusions:
- Further research into viral hepatitis pathogenesis is crucial for developing novel, safer, and more effective treatments.
- Future therapies should aim for shorter treatment durations and improved safety profiles.
- A concerted global effort is required to meet the 2030 goal of eliminating viral hepatitis as a public health threat.
Related Concept Videos
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Gastritis-I: Introduction and Types
Acute gastritis presents as a sudden inflammation triggered by various stressors to the stomach lining, such as exposure to corrosive agents, local irritants like aspirin and other NSAIDs, alcohol consumption, radiation therapy, physical trauma, severe burns, sepsis,...
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Viral Mutations

